Market Place
Sourcing Support
Infinity Pharma Provides Information on MARIO-8 Study Evaluating Eganelisib
10 Jul 2023 //
BUSINESSWIRE
Infinity Pharmaceuticals Reports Second Quarter 2022 Financial Results
09 Aug 2022 //
BUSINESSWIRE
Infinity Pharma Outlines Eganelisib Development Strategy, Provides 2022 Guidance
05 Jan 2022 //
BUSINESSWIRE
Encouraging Updated Data from Phase 2 MARIO-3 TNBC Trial Presented at 2021 SABCS
10 Dec 2021 //
BUSINESSWIRE
Infinity to Present at Piper Sandler Virtual Healthcare Conference
22 Nov 2021 //
BUSINESSWIRE
Infinity Provides Update for Eganelisib in Patients with Metastatic Urothelial
05 Jan 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.